tiprankstipranks
Trending News
More News >
Repare Therapeutics Inc (RPTX)
NASDAQ:RPTX
US Market

Repare Therapeutics (RPTX) Income Statement

Compare
447 Followers

Repare Therapeutics Income Statement

Last quarter (Q3 2025), Repare Therapeutics's total revenue was $11.62M, an increase of Infinity% from the same quarter last year. In Q3, Repare Therapeutics's net income was $3.26M. See Repare Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 53.48M$ 51.13M$ 131.83M$ 7.60M$ 135.00K
Gross Profit
$ 40.10M$ 37.89M$ 15.11M$ -80.25M$ -38.64M
Operating Expenses
$ 133.62M$ 154.12M$ 34.90M$ 28.41M$ 15.66M
Depreciation and Amortization
$ 1.92M$ 1.95M$ 1.98M$ 1.47M$ 897.00K
EBITDA
$ -90.22M$ -114.27M$ -17.82M$ -107.19M$ -53.41M
Operating Income
$ -93.52M$ -116.22M$ -19.80M$ -108.66M$ -54.30M
Other Income/Expenses
$ 10.27M$ 13.04M$ 5.90M$ 74.00K$ -440.00K
Pretax Income
$ -83.25M$ -103.18M$ -13.90M$ -108.59M$ -54.74M
Net Income
$ -84.69M$ -93.80M$ -29.05M$ -106.91M$ -53.42M
Per Share Metrics
Basic EPS
$ -2.00$ -2.23$ -0.69$ -2.83$ -1.45
Diluted EPS
$ -2.00$ -2.23$ -0.69$ -2.83$ -1.45
Weighted Average Shares Outstanding
42.41M 42.09M 41.92M 37.82M 36.90M
Weighted Average Shares Outstanding (Diluted)
42.41M 42.09M 41.92M 37.82M 36.90M
Currency in USD

Repare Therapeutics Earnings and Revenue History